Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: CHIMEROCYTE, INC.
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2022-09-29 to 2023-09-30
Current total value of award: $1092350.01
Description: STTR PHASE II CONTRACT ENTITLED IODIDE FOR THE TREATMENT OF INFLUENZA AND OTHER STRESSES